about
New Directions in Chronic Disease ManagementDevelopment of Clinical Data Mart of HMG-CoA Reductase Inhibitor for Varied Clinical Research.Efficacy of the smartphone-based glucose management application stratified by user satisfaction.Effects of 6-Month Sitagliptin Treatment on Insulin and Glucagon Responses in Korean Patients with Type 2 Diabetes Mellitus.The differences in the incidence of diabetes mellitus and prediabetes according to the type of HMG-CoA reductase inhibitors prescribed in Korean patients.Analysis and comparison of the cost-effectiveness of statins according to the baseline low-density lipoprotein cholesterol level in Korea.Change in ALT levels after administration of HMG-CoA reductase inhibitors to subjects with pretreatment levels three times the upper normal limit in clinical practice.Clinical experiences and case review of angiotensin II receptor blocker-related angioedema in KoreaEffect of visit-to-visit LDL-, HDL-, and non-HDL-cholesterol variability on mortality and cardiovascular outcomes after percutaneous coronary interventionDeveloping a multi-center clinical data mart of ACEI and ARB for real-world evidence (RWE)Proceed with Caution When Using Real World Data and Real World EvidenceEffects of Variability in Blood Pressure, Glucose, and Cholesterol Concentrations, and Body Mass Index on End-Stage Renal Disease in the General Population of Korea.Effect of a Mobile Phone-Based Glucose-Monitoring and Feedback System for Type 2 Diabetes Management in Multiple Primary Care Clinic Settings: Cluster Randomized Controlled TrialReal-world Evidence versus Randomized Controlled Trial: Clinical Research Based on Electronic Medical RecordsDementia Research Using Healthcare Big DataThe short-term effects of angiotensin II receptor blockers on albuminuria and renal function in Korean patientsSerum Uric Acid and Metabolic Syndrome: a Retrospective Cohort StudyMedical Big Data Is Not Yet Available: Why We Need Realism Rather than ExaggerationDecision-Making in Artificial Intelligence: Is It Always Correct?Differences in Clinical Outcomes between Patients with and without Hypoglycemia during Hospitalization: A Retrospective Study Using Real-World EvidenceDiscontinuation rate and reason for discontinuation after sodium-glucose cotransporter 2 inhibitor prescription in real clinical practiceLessons from Temporary Telemedicine Initiated owing to Outbreak of COVID-19
P50
Q26801673-4810E65F-1623-48B1-A6E8-897C767567F3Q31170234-E4B0694F-E00D-44A2-BD36-29F6695D4FCCQ33441267-6655A3AB-DD36-4C3A-8BA1-540E7826F2A3Q35976493-E5CDB61B-1C20-4901-876F-5174F4412E17Q38757502-C219785C-1F17-4DAC-83B6-738AE1E454C4Q38934196-0E02C892-8E63-4A21-90DA-32035413A715Q49719078-F9E0EFAD-79D0-4D87-B89E-3D6587C71CAAQ57214729-4A182650-05CB-4759-B763-DEAF8DAA1737Q57813084-7937D16D-BED5-4CF8-B5C1-E553EDB7FA17Q60044596-9A4BD340-54D9-4035-ADE8-E592306EBAFBQ61447767-C08EFB04-8341-4512-9C76-E53E952E642EQ64889721-F552F117-789D-45F7-9027-CF70BEB6EDDFQ90036185-92AE378E-A944-4279-8185-27F3301DCBC9Q91050114-15125567-A528-478B-A6C0-8F822EE589F5Q91083370-F0A3F65B-9D45-4186-ABE6-91886465028CQ91437841-B043956C-7686-4B8C-867E-21A647612D73Q91946720-B4EFB13C-E130-4B13-96F9-CD16E6C426CAQ92302533-63DABAAC-EA59-4F13-B0D9-EA8B0B58CB45Q92391878-D2F8E4C3-11E8-4F2E-97BF-0D6342EAD461Q95283542-5AEF0549-FF84-4E9A-8970-4581D04ED50CQ96350481-9BE5D8DE-43C8-411B-A85E-419109A2D2AEQ96434700-C99D2A2C-ADD0-4BFC-B107-75B6E03115A6
P50
description
researcher ORCID ID = 0000-0002-7002-7300
@en
name
Hun-Sung Kim
@ast
Hun-Sung Kim
@en
Hun-Sung Kim
@es
Hun-Sung Kim
@nl
type
label
Hun-Sung Kim
@ast
Hun-Sung Kim
@en
Hun-Sung Kim
@es
Hun-Sung Kim
@nl
prefLabel
Hun-Sung Kim
@ast
Hun-Sung Kim
@en
Hun-Sung Kim
@es
Hun-Sung Kim
@nl
P31
P496
0000-0002-7002-7300